Related references
Note: Only part of the references are listed.Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma
Annette M. Molinaro et al.
JAMA ONCOLOGY (2020)
Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas
Florian Gessler et al.
NEUROSURGERY (2019)
The Role of Extent of Resection in IDH1 Wild-Type or Mutant Low-Grade Gliomas
Toral Patel et al.
NEUROSURGERY (2018)
Correlation Between the Residual Tumor Volume, Extent of Tumor Resection, and O-6-Methylguanine DNA Methyltransferase Status in Patients with Glioblastoma
Mayur Sharma et al.
WORLD NEUROSURGERY (2018)
Functional MRI vs. navigated TMS to optimize M1 seed volume delineation for DTI tractography. A prospective study in patients with brain tumours adjacent to the corticospinal tract
Carolin Weiss Lucas et al.
NEUROIMAGE-CLINICAL (2017)
Multimodal Imaging in Malignant Brain Tumors: Enhancing the Preoperative Risk Evaluation for Motor Deficits with a Combined Hybrid MRI-PET and Navigated Transcranial Magnetic Stimulation Approach
V. Neuschmelting et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection?
Yan Michael Li et al.
JOURNAL OF NEUROSURGERY (2016)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Stupp et al.
ANNALS OF ONCOLOGY (2014)
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
Matthew M. Grabowski et al.
JOURNAL OF NEUROSURGERY (2014)
Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma
Kaisorn L. Chaichana et al.
NEURO-ONCOLOGY (2014)
When Gross Total Resection of a Glioblastoma Is Possible, How Much Resection Should Be Achieved?
Kaisorn L. Chaichana et al.
WORLD NEUROSURGERY (2014)
How Much Is Enough? The Question of Extent of Resection in Glioblastoma Multiforme
Muhammad M. Abd-El-Barr et al.
WORLD NEUROSURGERY (2014)
Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival Clinical article
Daniel Orringer et al.
JOURNAL OF NEUROSURGERY (2012)
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmstrom et al.
LANCET ONCOLOGY (2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick et al.
LANCET ONCOLOGY (2012)
Low-grade gliomas in adults
Nader Sanai et al.
JOURNAL OF NEUROSURGERY (2011)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma
Andreana L. Rivera et al.
NEURO-ONCOLOGY (2010)
Standard Therapy for Glioblastoma-A Review of Where We Are
Ryo Nishikawa
NEUROLOGIA MEDICO-CHIRURGICA (2010)
Independent association of extent of resection with survival in patients with malignant brain astrocytoma
Matthew J. McGirt et al.
JOURNAL OF NEUROSURGERY (2009)
Assessing Tumor Response to Therapy
Wolfgang A. Weber
JOURNAL OF NUCLEAR MEDICINE (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Growth laws in cancer: Implications for radiotherapy
P. Castorina et al.
RADIATION RESEARCH (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Factors influencing survival in high-grade gliomas
JC Buckner
SEMINARS IN ONCOLOGY (2003)
Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project
ER Laws et al.
JOURNAL OF NEUROSURGERY (2003)
A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival
M Lacroix et al.
JOURNAL OF NEUROSURGERY (2001)
Share Paper
